Discover more from Courageous Discourse™ with Dr. Peter McCullough & John Leake
Which Virus Will Cause the Next Pandemic?
Experts Predict Virus Will Be Airborne--Narrows Field Considerably
By Peter A. McCullough, MD, MPH
We are constantly being barraged by fear-mongering messages about a “next pandemic” as if new global catastrophes have been put on a schedule. I have remarked that it would be quite difficult to anticipate an organism arriving from nature and afflicting the entire world’s population of any mammal, let alone man.
Neumann and Kawaoka published a review of past pandemics, a broad list of viral threats, and then indicated that the likely winner would be a zoonosis (virus that jumped from a bat or rodent) to a human. Additionally, for human to human spread it would need to be airborne and highly contagious. We learned with the fizzled Monkeypox scare that homo- bi-sexual transmission from man to man was not enough the scare the world into mass vaccination or hold the public captive very long in the news cycle. President Biden dropped the US Monkeypox Emergency in January 31, 2023 with no press release.
The list of possibilities for future pandemics is listed in the table. Most have no antiviral therapy that is specific, however, the authors fail to mention viricidal nasal sprays/gargles, vitamin D, curcumin, hydroxychloroquine, ivermectin, favipiravir, famotidine, or other agents to mitigate viral specific inflammation such as maraviroc and nonspecific agents including corticosteroids and colchicine.
The authors outline these steps to get ready: “To prepare for future pandemics, the international research community needs to continue and further strengthen research efforts in various areas, including the following: (i) cataloging the landscape and animal reservoirs of (human-infecting) viruses through surveillance and metagenomics; (ii) development of animal models for viruses that may cause pandemics; (iii) basic research to better understand the molecular virology of such viruses; (iv) early stage vaccine development and testing in animal models; and (v) development of broad antivirals as a first line of defense. The US National Institute of Allergy and Infectious Diseases has suggested that prototype pathogens (selected from virus families that may cause pandemics) be selected for basic research and early stage development of countermeasures. With reasonable resources and advanced technologies, the global community could be much better prepared for future pandemics.
I am cautious about the terms “animal models” “prototype pathogens” “vaccine” or “countermeasure” as these were the words used by the NIH, HHS, and the Cares Act disastrous COVID-19 pandemic response. I suggest we focus on readiness with an arsenal of nasal viricidal washes and gargles to PREVENT the upper respiratory illness as the main measure of contagion control. Solutions of dilute iodine, hydrogen peroxide, xylitol, colloidal silver, and other compounds alone or in combination should serve well for any of the viral threats listed.
From the authors (v) “broad antivirals” with adjunctive treatment will be the next line of defense since they will be readily available, scalable, and far more important to large numbers of sick patients instead of vaccines for well persons.
If you find “Courageous Discourse” enjoyable and useful to your endeavors, please subscribe as a paying or founder member to support our efforts in helping you engage in these discussions with family, friends, and your extended circles.
Cristina Cassetti M, Pierson TC, Jean Patterson L, Bok K, DeRocco AJ, Deschamps AM, Graham BS, Erbelding EJ, Fauci AS. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness. J Infect Dis. 2022 Jul 25:jiac296. doi: 10.1093/infdis/jiac296. Epub ahead of print. PMID: 35876700; PMCID: PMC9384504.